A Phase I trial of Bortezomib and Interferon Alfa-2B in Metastatic Melanoma

The possibility that cytokine administration could enhance the anti-tumor effects of proteasome inhibition was explored. It was found that co-administration of bortezomib and interferon-α (IFN-α) induced synergistic apoptosis in human melanoma cell lines and prolonged survival in a murine model of m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Markowitz, Joseph, Luedke, Eric A., Grignol, Valerie P., Hade, Erinn M., Paul, Bonnie K., Mundy-Bosse, Bethany L., Brooks, Taylor R., Dao, Thao-Vi, Kondalasula, Sri Vidya, Lesinski, Gregory B., Olencki, Thomas, Kendra, Kari L., Carson, William E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4174542/
https://ncbi.nlm.nih.gov/pubmed/24316557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000009
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares